Tadashi Nakamura Selected Research

Caplan Syndrome

1/2020

Amyloid A amyloidosis in a patient with Caplan's syndrome, with special reference to genetic predisposition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tadashi Nakamura Research Topics

Disease

23	Rheumatoid Arthritis 01/2020 - 12/2003
8	Atherosclerosis 09/2021 - 09/2002
7	Hypertension (High Blood Pressure) 01/2021 - 01/2003
7	Obesity 07/2014 - 09/2003
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2011
6	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2004
5	Inflammation (Inflammations) 03/2022 - 01/2008
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2008 - 04/2004
4	Hyperglycemia 01/2022 - 09/2003
4	Insulin Resistance 08/2005 - 09/2002
4	Hypoadiponectinemia 11/2004 - 09/2002
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2002
3	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 09/2011
3	Necrosis 01/2019 - 03/2007
3	Hypertriglyceridemia 07/2014 - 01/2010
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2004 - 01/2003
2	Familial Mediterranean Fever (Periodic Disease) 03/2022 - 03/2014
2	Pancreatitis 01/2022 - 01/2010
2	Diabetes Mellitus 09/2021 - 01/2003
2	Rheumatic Diseases (Rheumatism) 02/2020 - 12/2017
2	Body Weight (Weight, Body) 01/2020 - 08/2010
2	Lung Diseases (Lung Disease) 01/2020 - 01/2016
2	Adult-Onset Still's Disease 12/2018 - 12/2017
2	Synovitis 11/2018 - 09/2005
2	Hyperuricemia 11/2011 - 06/2011
2	Dyslipidemias (Dyslipidemia) 06/2011 - 01/2003
2	Abdominal Obesity 06/2011 - 03/2005
2	Xanthomatosis (Xanthoma) 01/2010 - 08/2005
2	Infections 09/2006 - 07/2002
2	Secondary Hyperparathyroidism 09/2005 - 08/2005
2	Amyloidosis 12/2004 - 12/2003
2	Vomiting 01/2004 - 05/2003
2	Hyperlipoproteinemia Type III (Broad Beta Disease) 06/2003 - 06/2003
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2022
1	Autonomic Nervous System Diseases (Dysautonomia) 02/2020
1	Autoimmune Diseases (Autoimmune Disease) 02/2020
1	Carotid Artery Diseases 01/2020
1	Caplan Syndrome 01/2020
1	Pneumoconiosis 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Tardive Dyskinesia 05/2019
1	Dementia (Dementias) 05/2019
1	Nasopharyngitis 01/2019
1	Bronchitis 01/2019

Drug/Important Bio-Agent (IBA)

20	AdiponectinIBA 01/2021 - 06/2002
12	AA amyloidosisIBA 03/2022 - 12/2003
8	Amyloid (Amyloid Fibrils)IBA 01/2020 - 12/2003
6	Glucose (Dextrose)FDA LinkGeneric 09/2021 - 10/2002
5	HLA-DRB1 Chains (HLA DRB1)IBA 12/2017 - 11/2006
4	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 09/2021 - 10/2017
4	HDL LipoproteinsIBA 01/2021 - 08/2005
4	Biomarkers (Surrogate Marker)IBA 11/2018 - 12/2003
4	Etanercept (Enbrel)FDA Link 11/2012 - 01/2008
3	Monoclonal AntibodiesIBA 03/2022 - 09/2005
3	EnzymesIBA 01/2022 - 01/2013
3	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2021 - 10/2017
3	Triglycerides (Triacylglycerol)IBA 01/2021 - 08/2005
3	CholesterolIBA 01/2021 - 03/2005
3	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 01/2005
3	Insulin (Novolin)FDA Link 06/2012 - 10/2002
2	PyrinIBA 03/2022 - 03/2014
2	Colchicine FDA LinkGeneric 03/2022 - 03/2014
2	InflammasomesIBA 03/2022 - 12/2018
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2020
2	Lipase (Acid Lipase)FDA Link 01/2022 - 01/2010
2	SodiumIBA 09/2021 - 10/2017
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 04/2004
2	HDL CholesterolIBA 01/2021 - 12/2008
2	AutoantibodiesIBA 02/2020 - 01/2007
2	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 12/2004
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2015
2	Hemoglobins (Hemoglobin)IBA 09/2013 - 06/2011
2	Peroxidase (Myeloperoxidase)IBA 01/2013 - 01/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2012 - 12/2003
2	EpitopesIBA 01/2012 - 11/2006
2	Biological ProductsIBA 09/2011 - 07/2002
2	AdipokinesIBA 01/2011 - 11/2009
2	Lipoproteins (Lipoprotein)IBA 03/2005 - 06/2003
1	Immunoglobulin G (IgG)IBA 03/2022
1	InterleukinsIBA 03/2022
1	canakinumab FDA Link 03/2022
1	Amylases FDA Link 01/2022
1	KetonesIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	LuciferasesIBA 02/2020
1	Cholinergic ReceptorsIBA 02/2020
1	AntibodiesIBA 02/2020
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2020
1	Sodium-Glucose Transport ProteinsIBA 01/2020
1	Coal (Coals)IBA 01/2020
1	Pharmaceutical PreparationsIBA 05/2019
1	Domperidone (Domperidon)IBA 05/2019
1	namilumabIBA 01/2019
1	Biological FactorsIBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2019 - 09/2005
2	Glycemic Control 10/2017 - 09/2013
2	Biological Therapy 09/2011 - 12/2010